Study shows HAART reduced inpatient costs.

A nationwide study presents a clear picture of how highly active antiretroviral therapy has reduced inpatient hospital costs for HIV patients, but the benefits of antiretroviral therapy are less pronounced among women, minorities, and poor people infected with HIV.